Overview

Cervical Ripening in Obese Women: Efficacy of 25 mcg Versus 50 mcg of Misoprostol

Status:
Unknown status
Trial end date:
2021-03-01
Target enrollment:
Participant gender:
Summary
This is a prospective clinical trial to determine if 50 mcg versus 25 mcg po every four hours of misoprostol has improved efficacy and similar safety in obese women undergoing cesarean section.
Phase:
N/A
Details
Lead Sponsor:
University of Cincinnati
Treatments:
Misoprostol